Neuspera SNM System follow-up: comparing patient experience with traditional SNM
Official title: Follow-up Revision Experience and Evaluation of Device Outcomes Metrics in Subjects Receiving Replacement of Traditional Sacral Neuromodulation (SNM) With the Neuspera SNM System
Run by Neuspera Medical, Inc. · NCT07383688 · Data updated 2026-11-12
We’re testing whether patients who switch from a traditional sacral neuromodulation device to the Neuspera SNM System report similar or better experiences after about one month.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Neuspera Medical, Inc. Industry-sponsored |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT07383688 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 22 years or older who have or recently had a traditional SNM device and meet response criteria in prior bladder diaries.
✕Probably not a fit
Patients who do not experience perceived improvement or who have contraindications to Neuspera may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, single-arm study will enroll up to 20 adults with urinary urge incontinence who currently have or recently removed a traditional SNM device and are receiving the Neuspera implant. Participants complete a pre-implant questionnaire about their experience with the traditional SNM and then undergo implantation of the Neuspera device followed by a 1-month follow-up. The study uses standard-of-care implantation and aims to compare patient-reported outcomes after switching devices. Data will describe perceived changes in comfort, effectiveness, and overall satisfaction related to the Neuspera system.
Why it matters
Potential benefit: If successful, patients may experience improved satisfaction and perceived effectiveness after switching to Neuspera SNM.
How similar studies have gone: Previous SNM device changes have shown variable but informative patient-reported outcomes; this study adds a focused comparison for Neuspera in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Currently have a traditional SNM device and has decided to have the device replaced with the Neuspera SNM System OR previously had an existing traditional SNM implant that was completely removed within the last year 2. Is 22 years of age or older 3. Had documented at least 50% improvement in UUI episodes on a bladder diary with either a stimulation trial or with their traditional system 4. Is a good surgical candidate and qualified to receive the Neuspera SNM System per the device labeling 5. Is capable of participating in all testing and follow-up clinic visits associated with this clinical study. Exclusion Criteria: 1. Has a contraindication for the Neuspera SNM System per the device labeling. 2. Has plans to enroll or is currently enrolled in another investigational device or drug trial during his/her participation in this study
Where it's running
-
Specialty Clinical Research of St. Louis
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Kellen Choi, DO — University of Louisville Health System
- Study coordinator: Mark Vollmer
- Email: mark.vollmer@neuspera.com
- Phone: 408-433-3839
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
30-minute Neuspera sacral neuromodulation for urinary urge incontinence
This trial will try daily 30-minute sacral nerve stimulation with the Neuspera System to reduce urinary urge incontinence in adults who have not benefited from or cannot tolerate bladder medications.
-
Electrical stimulation to reduce urinary incontinence in men after prostate cancer treatment
This study tests if using a device that sends electrical impulses can help men who have had prostate cancer treatment reduce urinary incontinence.
-
Evaluation of eCoin for treating urgency urinary incontinence
This study is testing whether an implanted device called eCoin can help people with urgency urinary incontinence feel better over the long term.
-
Comparing pain from different numbers of bladder injections of Botox
This study is testing whether getting 5 or 20 Botox injections for overactive bladder causes more pain in women who haven't found relief from other treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.